Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 40 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

10%

4 trials in Phase 3/4

Results Transparency

100%

2 of 2 completed trials have results

Key Signals

10 recruiting2 with results

Enrollment Performance

Analytics

N/A
13(56.5%)
Phase 1
3(13.0%)
Phase 2
3(13.0%)
Phase 3
2(8.7%)
Phase 4
2(8.7%)
23Total
N/A(13)
Phase 1(3)
Phase 2(3)
Phase 3(2)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (40)

Showing 20 of 40 trials
NCT07523724Not ApplicableNot Yet Recruiting

Screening and Management of Adults With Asthma and Allergic Diseases

Role: collaborator

NCT07253948Recruiting

Distribution Characteristics of Helicobacter Pylori

Role: lead

NCT05697588Recruiting

Exploring the Predicting Biomarkers From Mild Cognitive Impairment to Dementia (EBMID)

Role: collaborator

NCT06783933Active Not Recruiting

Artificial Intelligence-assisted Diagnosis

Role: collaborator

NCT04201717Not ApplicableActive Not Recruiting

Intracorporeal Anastomosis Versus Extracorporeal Anastomosis for Left Colon Cancer

Role: lead

NCT06454461Not ApplicableRecruiting

Efficacy of Upadacitinib After NECS in Vitiligo

Role: lead

NCT06655090Recruiting

Fibrotic Interstitial Lung Disease Early Recognition and Strategic Therapy Study in China

Role: collaborator

NCT06097013Enrolling By Invitation

Study of Brain Function Evaluation System for Acute and Prolonged Disorders of Consciousness

Role: collaborator

NCT05682248Not ApplicableEnrolling By Invitation

Study of Brain Function Evaluation and Intervention System for Acute and Prolonged Disorders of Consciousness

Role: collaborator

NCT06397066Recruiting

White Light Endoscopy and Magnifying Endoscopy in Assessing the Status of Hp Infection

Role: lead

NCT02889666Phase 1Recruiting

A Randomised Trial of Chemotherapy Plus Surgery for Recurrent Non-Small Cell Lung Cancer

Role: collaborator

NCT06079554Recruiting

Microbiota and Metabolomics of Intestinal Type of Gastric Cancer

Role: lead

NCT06076382Not ApplicableRecruiting

Endoscopic Ultrasound Guided Colorectal ESD and Traditional Colorectal ESD Surgery

Role: lead

NCT06076369Recruiting

Differentiation of Tubular Adenoma and Colonic Innominate Groove Under EC Endoscopy

Role: lead

NCT06189586Not ApplicableUnknown

Comparison of Aerosol Inhalation and Intravenous Glucocorticoid in the Treatment of Severe AECOPD

Role: collaborator

NCT06078839Phase 4Not Yet Recruiting

Nafamostat Mesilate in the Treatment of Severe Infection-associated Coagulopathy

Role: collaborator

NCT05913362Not ApplicableUnknown

IVUS Guided PCI for CKD to Reduce CI-AKI

Role: lead

NCT05892042Not ApplicableUnknown

Anti-CoagulaTion on Left Ventricular Thrombus After ST Segment Elevation Myocardial Infarction

Role: lead

NCT05810324Not ApplicableUnknown

18F-FAPI PET/CT in Patients With Various Types of Cancer

Role: lead

NCT05806333Not ApplicableUnknown

[18F]FAPI PET/CT in Suspicious Focal Liver Lesions Without FDG Avidity

Role: lead